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Abstract 
The exceptional progress in obstetrics, especially in the second half of the 20th century, creates 
a series of dilemmas, without having yet the answer to old, basic questions, such as premature delivery 
and prevention of preeclampsia. Sexual liberty and the delay of the first pregnancy are responsible for 
the drop in natality rate and the increasing demand for assisted reproductive technologies. Their success 
is marked, though, by a drastic increase in the multiple birth rate and its complications. The advancing 
maternal  age  brings  along  a  number  of  cardiovascular  pathologies  that  endanger  not  only  the  present 
pregnancy,  but  also  the  long  distance  health  prognosis.  Plus,  there  is  a  marked  risk  for  foetal 
chromosomal anomalies, which explains the need and the importance of prenatal diagnosis. Probably the 
newest branch in materno-foetal medicine, it offers many answers and solutions, but there are still a lot 
of question marks. In conclusion, the progress is necessary, is expected, but it should always be filtered 
by time and experience. 
 
Obstetrics, a science born at the same time with human kind, having been crucially 
assimilated within its development and progress, has slowly evolved through thousands of 
years and today, we like to think that we have reached a point that comes close to the apex 
of our pyramid of knowledge. A peak where there are no longer uncertainties, where we 
do  not  longer  have  materno-foetal  mortality  and  morbidity  statistics,  where  human 
reproduction is a risk free phenomenon. Reality unfortunately, begs to differ. 
The road of obstetrics may begin with Hippocrates, the one who assumed that birth 
is triggered by the foetus who “becomes agitated and thus breaks the membranes”, may 
continue with Leonardo da Vinci who, during the Renaissance, struggles to imagine the 
intrauterine development of the foetus, noting that it “has a daily growth inside the womb 
that surpasses its growth after birth”. 
All  great  humanists,  regardless  of  the  period  in  time  in  which  they  lived  and 
thought, were preoccupied by the decryption of the intrauterine growth mystery. What the 
twentieth century and especially its second half brings new, is the concern to treat and to 
prevent complications associated to pregnancy and birth. The development of molecular 
biology  and  genetics,  the  understanding  of  physiological  mechanisms  and  their 
pathological alterations, the spectacular progress of computer technology with its potential 
applications in medicine, have cleared up for good the mystery of emergence of the human 
race,  which  was  transformed from  a  myth  into  a  science  with  numerous  extensions  and 
overspecializations, a science where the assistance of birth, a hundred years ago the basis 
of  the  trade,  is  now  of  secondary  importance.  Thus,  at  this  moment,  it  is  more 
appropriately to replace the term “obstetrics” with the one “maternofoetal medicine”, more 
comprehensive and including both participants of this inseparable partnership. 
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The  peak  of  the  pyramid  is  still  far.  Even  though  outnumbered  hypotheses  were 
issued,  many  theories  were  made,  a  great  deal  of  studies  were  elaborated,  thousands  of 
articles  and  papers  were  written,  the  statistical  numbers  are  tough  and  show  that  the 
percentage of premature births is still high, almost unchanged in the last decades and the 
impairments caused by them constitute a great social, moral and economic burden, even in 
the developed countries with high medical standards. To be more precise in this matter, it 
must  be  noted  that  in  2005  in  the  United  States,  12.7%  of  all  births  were  premature, 
understanding by this a gestational age of less than 37 finished weeks or 259 days. 2.03% 
happened before 37 weeks while 9.1% happened between 34 and 36 weeks [1]. This aspect 
reflects an increase of 20% in the percentage of prematurity in comparison with 1990. How 
can this phenomenon be explained within the context of scientific and financial efforts to 
detect high risk of prematurity in pregnant women and to obtain pharmacological classes 
with  high  potential  of  reducing  uterine  contractility.  The  answer  lies  in  the  increased 
incidence of gemellar, triple and even more that triple pregnancies. The same statistical data 
reveal that between 1996 and 2002 multiple pregnancy rate rose up to 20 to 33% in a 1000 
live births (a medium of 31/1000 for gemellar pregnancies) [2]. In comparison to one foetus 
pregnancies, with an overall preterm birth risk of approximately 10%, gemellar pregnancies 
have a 50% risk of being delivered before 37 weeks, and in triple pregnancy cases, this risk 
goes  up  to  90%.  But  as  it  is  well  known,  preterm  delivery  implies  low  weight  at  birth, 
frequent  incomplete  development  of  the  respiratory  system,  with  consequent  distress  of 
variable severity, immaturity of the digestive tract, neurological frailty and possibly long 
term  impairment.  Thereby,  almost  50%  of  neonatal  deaths  happen  to  those  1,5  newborns 
who weigh less than 1500 grams [3].  Between 1500 grams and 2500 grams there is also an 
addition  of  20%  mortality  rate  so  that  the  relationship  between  gestational  age  and 
morbidity and mortality is clear and decreases exponentially as normal term comes nearer 
and nearer. Following the same line of thought, the survivors of a preterm birth at 26 weeks Journal of Medicine and Life  Vol. 1, No.1, January-March 2008 
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have a 60% incidence of impairment and disability, compared to the 30% rate for those born 
at  31  weeks  [4].  Neonatal  intensive  care  therapy  has  known  a  great  progress  and  has 
increased  survival  chances  of  premature  babies,  although  far  from  being  an  absolute 
resource as the above statistics have presented. 
Multiple  pregnancy  constitutes  a  true  epidemic  of  the  last  decade,  having  been 
undoubtedly  a  result  of  clinical  success  of  assisted  reproduction  techniques.  In  natural 
conditions, the incidence of twin pregnancies is 1 to 80 and that of triple pregnancies is 1 to 
8000,  according  to  Hellin’s  law.  In  practice  though,  in  the  United  States,  in  2002  twin 
pregnancies made up 4% of all births and triple pregnancies, 3% [5]. The increased number 
of triple and more than triple pregnancies is especially evident, but there is hope of reducing 
this phenomenon in the following years due to the control of the number of embryos that 
can be transferred within a cycle of in vitro fertilization. This was a logical measure that the 
authorized  medical  world  has  taken  to  decrease  complications  linked  with  multiple 
pregnancies and it is more strictly applied in European countries. 
A sensible question is why there is an increased appeal to the assisted reproduction 
services. The way of life in particular of population in developed countries, emancipation of 
women, sexual liberation, effective hormonal contraception, planned delay of maternity in 
order to favour professional success, imbalance in the institution of family, all these have 
contributed to the decrease of natality in particular by the aging of gametes and the rise in 
endometriosis  and  pelvic  inflammatory  disease  incidence.  It  is  difficult  to  asses  the 
prevalence of infertility prior to the sixties, when it was regarded as a sporadic infliction. 
Though we know that in 1982, 11% of female American population that sought to become 
pregnant had fecundity issues, in 2002 this percentage rose to 15% [6]. According to a study 
made by WHO on 8500 infertile couples, in 37% of them the cause was feminine and only 
8% was masculine. In 35% of cases the aetiology was mixed, feminine and masculine [7]. 
The advanced maternal age may also generate other complications. First, women over 
40 years of age tend to associate a series of pathologies like gestational diabetes, obesity, 
chronic hypertension, especially renal hypertension. The incidence of preeclampsia in this 
category  of  women  is  high,  in  particular  if  it  is  their  first  pregnancy.  Maternal  age 
represents an independent significant risk factor for the development of preeclampsia (RR 
1.96, 95% CI 1.34-2.87) [8]. 
Although  it  is  one  of  the  first  complications  of  pregnancy  that  has  been  isolated, 
identified and thoroughly described by obstetrics classics, in the age of genetic diagnosis in 
maternal blood, in utero therapy and stem cells, preeclampsia still constitutes an unresolved 
problem, a major source of maternal mortality and morbidity for which there are yet few 
efficient therapeutic resources, affecting between 10 to 20% of all pregnancies. Namely a 
“disease  of  theories”,  which  illustrates  the  frailty  of  the  ground  on  which  its 
physiopathological vision has been built, having as a result a poor efficiency of treatment, 
its definition criteria have little been changed since its first description.  As the complexity 
of  this  disease  is  revealed  step  by  step,  the  list  of  biological  alterations  that  accompany 
preeclampsia grows accordingly. This does not seem to improve significantly the prognosis 
of these pregnancies but merely complicates the specialists’ goal. In long term, a women 
who has developed early preeclampsia, has a high risk of cardiovascular disease and by that 
understanding hypertension, cardiac ischemic disease, stroke and cardiac death. 
This relative risk varies between 3.5 and 1.5, depending on studied population and 
criteria of definition [9, 10]. These studies show that women with preeclampsia history have 
an  alteration  of  endothelial  function  and  a  vasodilation  distanced  to  their  pregnancy. 
Vascular  change  is  accompanied  also  by  insulin  resistance,  sympathetic  and 
proinflammatory  hyperactivity,  alteration  of  the  lipidic  profile,  all  these  representing 
elements of metabolic syndrome which is responsible of changing long term prognosis. 
It  is  not  clear  to  what  extent  these  metabolic  changes  can  be  lowered  or  even  be 
avoided completely by an effective therapy of the hypertension episode in pregnancy. It is Journal of Medicine and Life  Vol. 1, No.1, January-March 2008 
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well  known  that  the  origin  of  these  changes  lies  in  the  early  stage  of  pregnancy,  in  the 
period of trophoblastic invasion, while consequences appear much later. That’s why, efforts 
are aimed at the prediction and prevention of this disease. A good screening test should be 
simple,  certain,  quick,  cheap  and  reproducible  and  should  allow  medical  intervention  in 
order to prevent the disease or at least improve its prognosis. 
The first predictive test used was the “roll-over test”, which, although efficient, was 
proven to be outdated. Serum measurements of angiogenic factors such as VEGF or PIGF 
(placental growth factor), angiogenic proteins, like soluble endogline (sEng) or fragments of 
VEGF type 1 receptor (s-Flt1), also known as fms-like tyrosine-kinase, prove to be more 
useful though hardly accessible. Thus, in the serum of women at risk of preeclampsia there 
is  an  increased  ratio  between  s-Flt1  and  sEng  and  a  decreased  ratio  between  VEGF  and 
PlGF,  which  determine  a  diffuse  endothelial  lesion,  with  alteration  in  the  capillary 
permeability  [11].  These  changes  happen  months  before  clinical  manifestations.  Same 
changes can be observed also in urine. 
Uterine  artery  Doppler  ultrasonography  is  one  of  the  most  known  prediction 
techniques.  Through  its  simplicity,  it  has  also  been  established  as  a  screening  technique 
although its flaws are many, having great inter-observer variations and not being considered 
appropriate  for  a  screening  test.  Even  with  these  in  mind,  a  met  analysis  of  43  studies, 
which included 42000 women, revealed that a positive Doppler test increases a woman’s 
risk  from  2,5%  (baseline  risk  in  general  population)  to  8  –  15%,  while  a  negative  test 
decreases this risk to 1,5% [12]. Theoretically at least, recognition of 90% of women who 
will develop early preeclampsia is made possible. 
Similarly, although hyperuricaemia is frequent in preeclamptic women and there was 
a lasting idea that uric acid levels grow a few weeks before tensional values grow as well, a 
series  of  recent  studies  have  proven  that  this  test  does  not  have  a  predictive  value  and 
therefore can not be used in screening [14]. 
In  these  conditions,  clinical  routine  evaluation,  with  systematic  measurement  of 
arterial pressure and look out for preeclampsia signs, has a predictive value similar to the 
most costly and newest diagnostic tests. That is, we are exactly where we left off. 
Another  controversial  area  is  the  prenatal  diagnosis,  a  completely  new  science, 
developed at the same time with ultrasonography and genetics. Clearly, it is the domain with 
the greatest progress and hopes for the future. If 30 years ago ultrasound served generally to 
confirm  the  position  of  foetus,  its  cardiac  activity  and  at  most,  the  diagnosis  of  brutish 
structural anomalies, now we track down discrete facial dimorphisms and the lack of corpus 
callosum formation. Technical progress has introduced the spirit of competition, imposed 
the  re-evaluation  of  fine  anatomy  and  embryology  data  with  continuously  up-to-date  and 
new  information  in  the  field  of  biology  and  genetics.  In  this  way,  there  has  been  an 
evolution  to  the  point  of  prenatal  detection  of  some  pathologies  that  don’t  even  have  a 
known prognosis and there are not few the situations when we encounter couples who ask 
pregnancy termination because the foetus has an isolated great cisterna magna or a partial 
corpus callosum agenesis. There is also the reverse of the coin. The numerous serological 
and  ultrasound  tests  confuse  doctor  and  patient  alike,  the  patient  refusing  thus  any 
additional investigation guided by her faith and optimism. Amniocentesis, umbilical cord 
centesis, trophoblastic biopsy can constitute effective diagnosis means but at the same time 
as many risks for the evolution of pregnancy. 
Following  the  diagnosis,  an  in  utero  therapy  has  been  developed.  Starting  with 
Harrison who in the eighties performed the first intervention of this kind for a foetus with 
diaphragmatic hernia, there is a shift to a more conservative approach. Of course that the 
defect may be repaired before birth, but this does not improve too much the prognosis of the 
foetus  who  is  consequently  exposed  to  prematurity.  Thus,  at  this  moment,  only  minimal 
repair surgeries are practiced, by means of foetoscopy or only under ultrasound guidance, in Journal of Medicine and Life  Vol. 1, No.1, January-March 2008 
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cases of low urinary tract obstruction, unilateral pleural effusion, diaphragmatic hernia or 
isolated ventriculomegaly. 
           Fig 2 in utero surgery 
 
Still, matters are far from ending at this point. Prenatal diagnosis in the future years 
will require the simple drawing of maternal blood in which foetal cells and foetal DNA will 
be isolated and used for all necessary tests. At least, that’s what we would like to believe. 
We do not know yet to what extent this will simplify matters or on the contrary become 
another gate to unknown realms, but we owe belief and support to progress, filtering though 
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